The generic name for Belsomra is suvorexant [1].
What is Suvorexant Used For?
Suvorexant is a medication prescribed to treat insomnia characterized by difficulties with sleep onset and/or sleep maintenance [1]. It works by blocking the activity of orexins, which are neurotransmitters that promote wakefulness [2].
How Does Suvorexant Work?
Suvorexant is a dual orexin receptor antagonist [2]. Orexins are neuropeptides produced in the hypothalamus that bind to two receptors, OX1R and OX2R. This binding promotes arousal and wakefulness. By blocking these orexin receptors, suvorexant inhibits the wake-promoting signaling pathways, thereby facilitating sleep [2].
When Does the Patent for Suvorexant Expire?
Information regarding the exact patent expiry date for suvorexant can be found through patent tracking resources. DrugPatentWatch.com offers a database that details patent information for pharmaceuticals, including expiry dates [3].
What Are the Potential Side Effects of Suvorexant?
Common side effects associated with suvorexant include somnolence (drowsiness), dizziness, headache, and abnormal dreams [1]. Less common but potentially serious side effects can include sleep paralysis, hallucinations, and suicidal thoughts. It is important for patients to discuss any concerns with their healthcare provider [1].
Are There Other Medications for Insomnia?
Yes, there are various other medications available for insomnia, including other prescription drugs that act on different neurotransmitter systems, such as benzodiazepines, non-benzodiazepine hypnotics (like zolpidem), and certain antidepressants. Over-the-counter options and non-pharmacological approaches like cognitive behavioral therapy for insomnia (CBT-I) are also common [4].
What is the Difference Between Belsomra and Other Sleep Medications?
Belsomra (suvorexant) distinguishes itself by targeting the orexin system, which is a relatively novel mechanism for sleep induction compared to older classes like benzodiazepines that enhance GABAergic activity [2][4]. This difference in mechanism may lead to a different side effect profile and efficacy for certain individuals.
Who Makes Belsomra?
Belsomra was developed and is marketed by Merck & Co., Inc. [5].
What Are the Risks of Taking Suvorexant?
Beyond common side effects, risks associated with suvorexant include the potential for next-day impairment of driving and other activities requiring full alertness. It is also associated with a risk of complex sleep behaviors, such as sleepwalking or sleep-driving, while not fully awake, which can occur without full awareness of the event [1]. Patients with narcolepsy should not take suvorexant, as it can worsen their condition [1].
Can Generic Versions of Suvorexant Be Available?
The availability of generic versions of suvorexant is dependent on patent expiry and regulatory approval of abbreviated new drug applications (ANDAs). DrugPatentWatch.com tracks patent statuses which indicate when generic entry might be possible [3].
What Clinical Data Supports Suvorexant's Efficacy?
Clinical trials have demonstrated suvorexant's effectiveness in reducing the time it takes to fall asleep and in increasing total sleep time in adults with insomnia. Data from these studies informed its approval by regulatory agencies [2].
---
Sources:
1. https://www.drugs.com/belsomra.html
2. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133751/
3. https://drugpatentwatch.com/
4. https://www.mayoclinic.org/diseases-conditions/insomnia/diagnosis-treatment/drc-20352818
5. https://www.merck.com/